0.5117

4.37% -0.0234

Heartbeam Inc (BEAT)

Overview News Price History Financials Discussions Forecast

Heartbeam Inc stock is traded at $0.5117, with a volume of 420.25K. It is down -4.37% in the last 24 hours and down -26.18% over the past month. HeartBeam Inc is a medical technology company focused on developing higher resolution ambulatory electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The company's proprietary and patented technology platform captures the heart's electrical activity from three dimensions and synthesizes a 12-lead ECG from these signals. The company has received U.S. Food and Drug Administration (FDA) clearance for its ECG solutions.

Previous Close:

$0.5351

Open:

$0.543

24h Volume:

420.25K

Relative Volume:

0.51

Market Cap:

$28.40M

Revenue:

Net Income/Loss:

$-20.23M

P/E Ratio:

-0.9108

EPS:

-0.5618

Net Cash Flow:

$-13.97M

1W Performance:

-8.46%

1M Performance:

-26.18%

6M Performance:

-71.73%

1Y Performance:

-60.02%

1-Day Range:

$0.5019

$0.543

1-Week Range:

$0.5019

$0.619

52-Week Range:

$0.5019

$4.00

Heartbeam Inc Stock (BEAT) Company Profile

Name

Heartbeam Inc

Sector

Healthcare (1071)

Industry

Health Information Services (47)

Phone

408-899-4443

Address

2118 WALSH AVE., SUITE 210, SANTA CLARA

Employee

Twitter

Next Earnings Date

2026-08-12

Latest SEC Filings

BEAT's Discussions on Twitter

Compare BEAT vs VEEV, BTSG, HQY, TEM, TXG

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
BEAT Heartbeam Inc	0.5117	28.40M	0	-20.23M	-13.97M	-0.5618
VEEV Veeva Systems Inc	186.24	30.25B	3.32B	941.65M	1.64B	5.6161
BTSG Brightspring Health Services Inc	72.91	14.31B	13.65B	169.86M	412.12M	1.0758
HQY Healthequity Inc	94.64	7.91B	1.34B	230.70M	440.96M	2.6695
TEM Tempus Ai Inc	42.69	7.69B	1.36B	-302.91M	-219.93M	-1.7182
TXG 10 X Genomics Inc	46.27	5.87B	638.78M	-22.66M	122.18M	-0.1744

Heartbeam Inc Stock (BEAT) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Apr-20-26	Downgrade	D. Boral Capital	Buy → Hold
Mar-31-26	Initiated	B. Riley Securities	Buy
Mar-27-26	Initiated	D. Boral Capital	Buy
Mar-16-26	Downgrade	The Benchmark Company	Buy → Speculative Buy
Dec-11-25	Upgrade	The Benchmark Company	Speculative Buy → Buy
Dec-08-25	Initiated	H.C. Wainwright	Buy
Oct-31-25	Initiated	Roth Capital	Buy
Sep-11-20	Initiated	Needham	Buy
Sep-02-20	Initiated	Robert W. Baird	Neutral
Jan-08-20	Initiated	SunTrust	Buy
Aug-02-19	Downgrade	Raymond James	Outperform → Mkt Perform
Apr-26-19	Reiterated	Dougherty & Company	Buy
Jul-26-18	Reiterated	Lake Street	Buy
Apr-26-18	Reiterated	The Benchmark Company	Buy
Feb-23-18	Reiterated	Dougherty & Company	Buy
Nov-08-17	Reiterated	Dougherty & Company	Buy
Oct-26-17	Initiated	Raymond James	Outperform
Oct-24-17	Initiated	SunTrust	Buy
Aug-09-17	Reiterated	Dougherty & Company	Buy
Jul-19-17	Reiterated	The Benchmark Company	Buy
Apr-11-17	Reiterated	Dougherty & Company	Buy
Dec-02-16	Initiated	Dougherty & Company	Buy
Sep-13-16	Initiated	Sidoti	Buy
Aug-03-16	Reiterated	The Benchmark Company	Buy
Jul-28-15	Reiterated	Dougherty & Company	Buy
Oct-24-13	Initiated	The Benchmark Company	Buy
Aug-21-13	Initiated	Dougherty & Company	Buy

View All

Heartbeam Inc Stock (BEAT) Latest News

03:37 AM

Form 4 Heartbeam Inc For: 25 July By Investing.com - Investing.com South Africa

03:37 AM

Jul 24, 2026

HeartBeam (NASDAQ: BEAT) CTO receives 105,740 shares in bonus grant - Stock Titan

Jul 24, 2026